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Abstract
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Fibronectin (Fn1) is an evolutionarily conserved extracellular matrix glycoprotein essential for
embryonic development. Global deletion of Fn1 leads to mid-gestation lethality from
cardiovascular defects. However, severe morphogenetic defects that occur early in embryogenesis
in these embryos precluded assigning a direct role for Fn1 in cardiovascular development. We
noticed that Fn1 is expressed in strikingly non-uniform patterns during mouse embryogenesis, and
that its expression is particularly enriched in the pharyngeal region corresponding with the
pharyngeal arches 3, 4, and 6. This region bears a special importance for the developing
cardiovascular system, and we hypothesized that the localized enrichment of Fn1 in the
pharyngeal region may be essential for cardiovascular morphogenesis. To test this hypothesis, we
ablated Fn1 using the Isl1Cre knock-in strain of mice. Deletion of Fn1 using the Isl1Cre strain
resulted in defective formation of the 4th pharyngeal arch arteries (PAAs), aberrant development
of the cardiac outflow tract (OFT), and ventricular septum defects. To determine the cell types
responding to Fn1 signaling during cardiovascular development, we deleted a major Fn1 receptor,
integrin α5 using the Isl1Cre strain, and observed the same spectrum of abnormalities seen in the
Fn1 conditional mutants. Additional conditional mutagenesis studies designed to ablate integrin
α5 in distinct cell types within the Isl1+ tissues and their derivatives, suggested that the expression
of integrin α5 in the pharyngeal arch mesoderm, endothelium, surface ectoderm and the neural
crest were not required for PAA formation. Our studies suggest that an (as yet unknown) integrin
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α5-dependent signal extrinsic to the pharyngeal endothelium mediates the formation of the 4th
PAAs.

Graphical abstract
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Congenital heart disease (CHD) is a common birth defect, with an incidence of nearly 1% in
newborns (Roger et al, 2011). The spectrum of abnormalities observed in CHD includes
defects in the morphogenesis of the aortic arch arteries (AAAs). Interruption of the aortic
arch is one of the most severe of these defects and is lethal unless corrected by surgery
(Moon, 2006, 2008). AAAs are an asymmetrical vascular tree that routes oxygenated blood
from the heart to the rest of the body. These blood vessels develop from three pairs of
pharyngeal arch arteries (PAAs) – numbered 3, 4, and 6 – that are initially organized
symmetrically around the midline (Kirby, 2007). Both the formation of PAAs and their
subsequent asymmetrical remodeling are necessary for proper AAA morphogenesis. In this
respect, mouse models of CHD indicated that AAA defects in patients with DiGeorge
syndrome were likely due to aberrant. PAA formation (Lindsay and Baldini, 2001; Lindsay
et al., 2001; Papangeli and Scambler, 2013a), while AAA defects in patients with Allagile
syndrome were likely the result of defective PAA remodeling (High and Epstein, 2008).
Taken together, these studies indicated that AAA morphogenesis is regulated over multiple
steps during embryo development. Therefore, understanding the genes and mechanisms that
regulate distinct steps in AAA morphogenesis will provide important insights into the
etiology of CHD.
Global Fn1-null embryos arrest their development by E9.5 and die from severe
cardiovascular defects (George et al., 1997; George et al., 1993). These embryos exhibit
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abnormal left-right patterning, defective development of the definitive endoderm, cardiac
outflow tract, and cardiac neural crest (Mittal et al., 2010, 2013; Pulina et al., 2011, 2014;
Villegas et al., 2013). However, it remained unclear whether cardiac and vascular defects
observed in global Fn1-null embryos resulted directly from the role of Fn1 in cardiovascular
development or from the earlier role of Fn1 in embryonic morphogenesis.

Author Manuscript

Integrins are a major class of Fn1 receptors (Wickstrom et al., 2011; Yang et al., 1999), and
at least 10 distinct integrins are known to bind Fn1 (Wickstrom et al., 2011). To understand
the mechanisms of Fn1 signal transduction during embryogenesis, several laboratories
generated global knockout mice by deleting Fn1 receptors singly or in combination. The
phenotypes of integrin α5-null embryos closely resemble those of Fn1-null mutants, while
knockouts of other Fn1 receptors (e.g. integrin heterodimers containing αv, α4, α8, or α9
chains) do not correspond with Fn1-null phenotypes (Huang et al., 2009; Wickstrom et al.,
2011; Yang et al., 1999). Furthermore, our recent studies indicated that embryonic
abnormalities related to defects in the left-right asymmetry, the development of the neural
crest, and cardiogenesis in global Fn1-null embryos closely resembled defects observed in
integrin α5-nulls (Mittal et al., 2010, 2013; Pulina et al., 2011, 2014; Villegas et al., 2013).
Significantly, embryos in which the Arg-Asp-Gly (RGD) integrin-binding site in Fn1 was
ablated displayed similar phenotypes when compared with integrin α5-null mutants
(Takahashi et al., 2007). These in vivo data, along with extensive molecular, biochemical,
and cellular studies over the past four decades, have established that integrin α5β1 binds
Fn1 and is a major Fn1 signal transducer. However, both the nature of the pathways activated
by Fn1-integrin α5β1 interactions in vivo and the role(s) of these pathways in cardiovascular
morphogenesis are virtually unknown.
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In our previous work, we discovered that the expression of Fn1 is dynamically regulated
during embryogenesis, and that Fn1 mRNA and protein are distributed in non-uniform
patterns within the developing mouse embryo (Mittal et al., 2010; Pulina et al., 2014;
Villegas et al., 2013). In particular, we noticed that at E9.5, Fn1 is highly enriched in the
pharyngeal arches 3, 4, and 6 (Mittal et al., 2010). Fn1 is essential for vertebrate
development and highly evolutionarily conserved (Hynes, 2012; Hynes and Zhao, 2000;
Whittaker and Hynes, 2002). Fn1 signals to cells by binding cell-surface integrins and
syndecans. Cell adhesion to Fn1 regulates numerous cell biological functions such as
proliferation, survival, and migration (Hynes, 2002, 2009; Schwartz, 2010; Schwartz and
Assoian, 2001). In addition, Fn1 binds a number of growth factors, including VEGF, HGF,
and many Fgfs (Giancotti and Tarone, 2003; Hynes, 2009; Martino and Hubbell, 2010;
Miyamoto et al., 1996; Wijelath et al., 2002). Many growth factors require integrin-mediated
cell adhesion to Fn1 for signaling (Giancotti and Tarone, 2003; Miyamoto et al., 1996).
Taken together, these studies suggest that the enrichment of Fn1 in distinct embryonic
regions may be important to modulate cellular responses to growth factors and to regulate
specific morphogenetic processes.
To test this hypothesis, we ablated Fn1 in the pharyngeal region using the Isl1Cre knock-in
strain of mice. In this strain, the Cre enzyme mediates recombination in several pharyngeal
tissues including the pharyngeal and splanchnic mesoderm, endoderm, surface ectoderm and
specific subpopulations of the cardiac neural crest (Cai et al., 2003; Engleka et al., 2012;
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Park et al., 2006). Our studies indicate that distinct, cell type-specific pharyngeal sources of
Fn1 play a number of distinct, indispensible roles in cardiovascular development and the
formation of the 4th pair of PAAs. Moreover, we found that the phenotypes of Fn1flox/−;
Isl1Cre and integrin α5flox/−; Isl1Cre mutants are similar with each other, indicating that
integrin α5β1 acts as a major Fn1 receptor in the pharyngeal tissues. We then employed a
series of conditional mutagenesis experiments to identify pharyngeal cell types, in which
integrin α5-dependent signals regulate the development of distinct cardiovascular features.

2. Materials and methods
2.1. Mouse strains and genotyping

Author Manuscript

Fn1+/− mice, integrin α5+/− mice and integrin α5flox/flox mice were a gift from Dr. Richard
Hynes (George et al., 1997; van der Flier et al., 2010; Yang et al., 1993). Fn1flox/flox mice
were a gift from Dr. Reinhardt Fassler (Sakai et al., 2001). Isl1Cre knock-in mice were a gift
from Dr. Sylvia Evans (Cai et al., 2003). RosamTmG mice, Gt (ROSA)26Sortm4(ACTBtdTomato,-EGFP) were purchased from Jackson labs (Muzumdar et al., 2007). Fn1+/− mice
or integrin α5+/− mice were crossed with Isl1Cre knock-in mice to generate Fn1+/−; Isl1Cre/+
or integrin α5+/−; Isl1Cre/+ males, respectively. To obtain embryos, Fn1flox/flox females were
crossed with Fn1+/−; Isl1Cre/+ males and integrin α5flox/flox females were crossed with
integrin α5+/−; Isl1Cre/+ males. Adult mice and embryos were genotyped as described (Cai et
al., 2003; George et al., 1997; Sakai et al., 2001; van der Flier et al., 2010). All experimental
procedures were approved by the Institutional Animal Care and Use Committee of Thomas
Jefferson University and conducted in accordance with federal guidelines for humane care of
animals.
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2.2. In situ hybridization
We generated the Fn1 in situ hybridization (ISH) probe and performed whole mount ISH
staining procedure, as described (Mittal et al., 2010). For the ISH on tissue sections, Fn1
probe recognizing the first exon of the Fn1 gene was purchased from the Advanced Cell
Diagnostics (cat # 316951, ACD, Hayward, CA, USA). Detection was done using
RNAscope 2.0 FFPE Assay Brown kit according to the manufacture’s protocol. After the
signal was developed, sections were counterstained with Gill’s hematoxylin.
2.3. Intracardiac injection of India Ink
Embryos were dissected at E10.5 and fixed with 4% paraformaldehyde at 4 °C overnight.
Embryos were rinsed with PBS and India ink injections were performed as described (Liang
et al., 2014).
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2.4. Immunofluorescence staining and histology
Dissected embryos were fixed with 4% paraformaldehyde at 4 °C overnight, rinsed in
phosphate buffered saline (PBS), and stored in PBS at 4 °C for no more than 2 weeks. For
paraffin embedding, embryos were processed through a graded series of alcohol and
xylenes. Hematoxylin and eosin staining as well as alcian blue and nuclear fast red staining
were done according to standard protocols. Alternatively, embryos were dehydrated through
graded methanol series and stored at − 20 °C. For frozen sections, embryos were incubated
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in 30% sucrose in PBS until they sunk and then in 50/50 mix of 30% sucrose and optimum
cutting temperature (OCT) compound (Tissue-Tek) at 4 °C overnight. Embryos were
embedded in a 50/50 mix of 30% sucrose and OCT and frozen using isopentane/dry ice
bath. The following primary antibodies were used to stain frozen sections: anti-integrin α5
(1:200, BD, cat #553319), anti-VEGFR2 (1:200, R&D, cat#AF644), anti-Pecam1 (1:200,
BD Pharmingen, cat# 553370), anti-PDGFRβ (1:100; R&D, cat#AF1042), anti-NG2 (1:100,
Millipore, cat#05-710), anti-ERG (1:100, Abcam, cat#ab110639). The following antibodies
were used for either frozen or paraffin sections: rabbit polyclonal against mouse Fn1 (1:500,
a gift from Dr. Richard Hynes lab, MIT) (George et al., 1993), anti-GFP (1:500, Aves labs,
cat #GFP-1020). For staining, sections were incubated with blocking buffer consisting of
10% Donkey serum in PBST (0.05% Tween 20 in PBS) for 1 h at room temperature (rt) and
then incubated with primary antibodies diluted in blocking buffer overnight at 4 °C. The
following day, sections were washed and then incubated with secondary antibodies: antimouse, anti-goat, anti-chicken, or anti-rabbit conjugated to Alexa-488, Alexa-555, or Alexa
647 (1:300, Invitrogen), or FITC-conjugated anti-chicken IgY antibodies (Jackson
Immunoresearch). Nuclei were either stained with DAPI (1:1000 dilution of 5 mg/ml stock
solution in H2O, Sigma, cat #32670-5MG-F) or DRAQ5 (1:1000 dilution of the stock
solution supplied by Cell Signaling Technology, catalog #4048,). To extinguish the native
tdTomato and memGFP fluorescence in frozen sections from embryos carrying the
ROSAmTmG allele(s), sections were dehydrated through graded series of methanol and
cover-slipped using glycerol:methanol (50:50) prior to imaging. For paraffin sections, the
native tdTomato and memGFP fluorescence was extinguished by boiling sections in 10 mM
Citric acid, pH6, for 10 min prior to staining. Slides were then mounted using ProLong®
Gold Antifade (Invitrogen). All fluorescence images were acquired using an Olympus
FV500 confocal microscope. Bright field images were acquired using Zeiss Axio Observer
inverted microscope and DFC420 digital color camera (Leica).
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For whole-mount immunofluorescence, embryos were isolated at E10.5 and fixed in 4%
paraformaldehyde at 4 °C overnight. After rinsing, embryos were permeabilized with
blocking buffer containing PBS, 0.1% Trixon X-100 (PBS-Triton) and 10% donkey serum at
4 °C overnight. The next day, embryos were incubated with anti-Pecam1 antibody (1:200,
BD Pharmingen, cat #550274) for 48 h at 4 °C. Embryos were then washed for 4 to 6 hours
using PBS-Triton and then incubated with Alexa-conjugated secondary antibodies (1:300,
Invitrogen). Embryos were then washed for 24 h at 4 °C and incubated with DRAQ5
(1:1000) for 48 h. All incubations were performed with gentle rocking. Prior to imaging,
embryos were dehydrated using a graded series of methanol and cleared using BABB
solution consisting of benzyl alcohol (Sigma B-1042): benzyl benzoate (Sigma B-6630) in a
1:2 ratio. Z-stacks were acquired using an Olympus FV500 confocal microscope and
analyzed using Imaris software (Bitplane, USA).
2.5. BrdU labeling
BrdU (Fisher Scientific, cat # BP2508250) was dissolved in PBS at 5 mg/ml. Pregnant
females were injected with this solution at the dose of 30 mg of BrdU per 1 kg of mouse
body weight when embryos reached E10.5 and were sacrificed 30 min after injection. To
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detect BrdU, sections were boiled for 10 min in 10 mM Citric acid solution, pH 6.0, and
then stained using rat monoclonal anti-BrdU antibody (1:100, Abcam, cat #ab6326).
2.6. Outflow track measurements
The lengths of the proximal and distal portions of the cardiac outflow tract (OFT) and the
height of the left ventricle were measured using the ruler tool in the AxioVision Zeiss image
acquisition software as shown in Fig. 10. To account for slight differences in the size of the
heart, the OFT measurements were normalized relative to the height of the left ventricle.
2.7. Quantitative RT-PCR
We isolated pharyngeal arches 3–6 from α5flox/+; Isl1Cre control and integrin α5flox/−;
Isl1Cre mutant embryos at E10.5. RNA isolation, RT-PCR, quantification and primers
sequences were as reported in (Liang et al., 2014).
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2.8. Statistical methods
All statistics were performed using Prism 6 version of Graph-pad software. Data were
analyzed using either 2-tailed unpaired Student’s t-test or 2-tailed Fisher exact test, as
indicated in the text and figure legends.

3. Results
3.1. Expression of Fn1 in tissues derived from Isl+ progenitors is required for
cardiovascular morphogenesis
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Our previous studies indicated that the expression of Fn1 mRNA was enriched in the
pharyngeal region corresponding with pharyngeal arches 3, 4, and 6 at E9.5 (Mittal et al.,
2010). Since the sequence of Fn1 is highly conserved in all vertebrates and is required for
cardiovascular morphogenesis, we hypothesized that both tissue-specific synthesis of Fn1
and signaling by Fn1 to specific tissues were important for embryonic and cardiovascular
development.
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To test our hypotheses, we conditionally ablated Fn1 expression using the Isl1Cre knock-in
strain. The expression of Cre in this strain mediates loxP-dependent recombination in tissues
that closely match those expressing Fn1 (Fig. 1A–A′, B–B′) and leads to specific ablation
of Fn1 mRNA and protein in the pharyngeal region (Fig. 1B–E, 1B′–E′). The remaining
Fn1 protein, as will be discussed later, is synthesized by the neural crest (long arrows in Fig.
1B–E) and in neural crest-derived cells (an open arrowhead in Fig. 1E′). We found that
conditional deletion of Fn1 in Fn1flox/−; Isl1Cre mutants resulted in late embryonic/early
neonatal lethality in the majority of the cases (Table 1) and displayed a variety of
cardiovascular and glandular abnormalities (Fig. 2 and Table 2). Gross dissection of E16.5
mutant and control embryos indicated that the majority of Fn1flox/−; Isl1Cre mutants
exhibited defects in the morphogenesis of the AAAs, which included the interrupted aortic
arch type B (IAA-B) (compare Fig. 2A and F), aberrant origin of the right subclavian artery
resulting in retroesophageal right subclavian artery (RERSA) (compare Fig. 2B and G,
dotted line underlines RERSA), and defects in the branching of the carotid arteries (compare
Fig. 2C and H), Table 2.
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In addition to vascular abnormalities, we also found membranous and muscular cardiac
ventricular septal defects (VSD) in n = 6/11 mutants (compare Fig. 2D–E with Fig. 2I–J).
The positions of the great vessels, relative to the left and right ventricles of the heart, were
unaffected in the majority of Fn1flox/−; Isl1Cre mutants, except in one instance of the double
outlet right ventricle (DORV) and one instance of persistent truncus arteriosus (PTA;
compare Fig. 2K and M). In addition, most of the mutants developed nodules of subaortic
cartilage, n = 7/11 (compare Fig. 2K, K′ and 2N, N′), and displayed defects in thymus
morphogenesis, n = 7/11 (compare Fig. 2L, L′, and 2O, P), Table 2. Myocardial thickness
and trabeculation were unaffected in the majority of Fn1flox/−; Isl1Cre mutants, n = 10/11.
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The presence of membranous VSD was previously associated with direct and indirect
defects in neural crest development (Hutson and Kirby, 2007). Intriguingly, recent studies
using the Isl1Cre knock-in mice showed that Cre recombinase in this strain is activated in
some populations of the neural crest-derived cells (Engleka et al., 2012). To test whether Isl1
was expressed in the descendants of neural crest cells invading the cardiac outflow tract
(OFT), we performed lineage-tracing studies using TFAP2αIRESCre to label neural crestderived cells. Simultaneously, we co-labeled sections using the antibodies to Isl1. For these
and all other experiments involving immunofluorescence, the native GFP and tdTomato
fluorescence due to the expression of the ROSAmTmG reporter was extinguished, as
described in Methods. These experiments showed that Isl1 is expressed in the neural crestderived cells entering the cardiac OFT at E9.5 (Fig. 3A, A′). The majority of the neural crest
cells in pharyngeal arches 3 (Fig. 3B, B′) and 4 (Fig. 3C, C′) were Isl1-negative. This was
also the case at E10.5 (Fig. 3E–E′). To exclude the mesodermal origin of cells co-expressing
TFAP2α and Isl1 in the OFT, we performed lineage tracing using the Mesp1Cre strain (Fig.
3D–D′). Mesp1 is a transcription factor expressed in the earliest known mesodermal
progenitors, which give rise to anterior mesodermal derivatives including the myocardium
and endocardium of the heart (Saga et al., 2000). These fate-mapping experiments showed
that Isl1+; GFP+ double-positive cells in the OFT, as seen in Fig. 3A–A′, are indeed derived
from the neural crest and not from the mesoderm (arrows in Fig. 3D, arrowheads in 3D′).
Cells expressing Isl1 in E10.5 pharyngeal arches mainly compose the endoderm, surface
ectoderm, arch core mesoderm and PAA endothelium (Fig. 3E–E′ and 3F–F′).
Taken together, these studies suggest that the membranous VSD and the peri-aortic cartilage
observed in Fn1flox/−; Isl1Cre mutants are a direct consequence of Isl1Cre-mediated ablation
of Fn1 in neural crest-derived cells. Indeed, we found that the deletion of Fn1 in the neural
crest using either the TFAP2αIRESCre knock-in strain or the P3Pro-Cre transgenic line,
resulted in the membranous VSD (n = 11/32) and peri-aortic cartilage (n = 10/12) (Fig. 4).
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Neural crest-derived cells are also known to play a requisite role in thymus development,
contributing to the thymic capsule and the pericytes of thymic blood vessels (Foster et al.,
2008; Hutson and Kirby, 2007; Le Douarin and Jotereau, 1975). Since Fn1flox/−; Isl1Cre,
Fn1flox/−; TFAP2αIRESCre and Fn1flox/−; P3Pro-Cre mutants develop thymus defects (Fig.
2L, O, P and Fig. 4C, F, I, L), we examined the lineage relationships of cells composing the
thymus. We found that Isl1Cre is activated neither in thymic capsule cells nor in pericytes of
thymic blood vessels (Fig. 5A, A′), excluding direct effects on the neural crest-derived cells
in the thymi in Fn1flox/−; Isl1Cre mutants. Vascularization of thymi in Fn1flox/−; Isl1Cre
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embryos isolated at E16.5 appeared to be similar to that of controls; although, we noticed a
somewhat disorganized appearance of pericytes in n = 2/3 Fn1flox/−; Isl1Cre mutants
(compare Fig. 5B, B′ with 5D, D′, and 5C, C′ with 5E, E′). With the bulk of thymic tissue
derived from the Isl1+ pharyngeal endoderm of the 3rd pouch (Fig. 5A, GFP+ cells), our data
suggest that thymic defects in Fn1flox/−; Isl1Cre mutants are likely due to the direct role of
Fn1 in the development of this endodermal tissue and indirect role in the development of
neural crest-derived pericytes. Taken together, our data indicate that the expression of Fn1 in
Isl1+ cells and their descendants is required for ventricular septation, thymus development,
and AAA morphogenesis. These phenotypes fall within a spectrum of abnormalities found
in DiGeorge patients (Moon, 2008).
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Mouse models of DiGeorge syndrome indicate that AAA defects in DiGeorge patients,
including IAA-B and RERSA, result from abnormal formation of the 4th pharyngeal arch
arteries (PAAs) (Liao et al., 2004; Lindsay et al., 2001; Merscher et al., 2001; Papangeli and
Scambler, 2013a). In order to test whether this was the case in our mutants, we isolated
E10.5 embryos at the time when all three pairs of PAAs were well-formed in controls and
assayed PAA formation either by performing India ink injections into the hearts or by whole
mount immunofluorescence staining and imaging. These assays indicated that the left or the
right 4th PAAs were not formed properly in n = 8/18 Fn1flox/−; Isl1Cre mutants, Table 3
(compare Fig. 6A, B and C, D; compare Fig. 6E, F and Fig. 6G, H; and optical sections in
Fig. 6E′, F′ and Fig. 6G′, H′). To determine whether abnormal PAA formation resulted
from defective proliferation of endothelial cells, we labeled the embryos with BrdU in utero
and quantified the proportion of BrdU-positive endothelial cells in the 4th PAAs in controls
and Fn1flox/−; Isl1Cre mutants. These studies demonstrated that endothelial cell proliferation
was similar in mutants and controls (Fig. 6I), indicating that defective formation of the 4th
PAA was not due to differences in endothelial cell proliferation. The frequency of the 4th
arch PAA defects in Fn1flox/−; Isl1Cre mutants (44%) at E10.5 corresponds with the
frequency of RERSA and IAA-B observed at E16.5 in Fn1flox/−; Isl1Cre embryos (42%,
Table 2), indicating that AAA anomalies in these mutants arose from defective formation of
the 4th pair of PAAs.
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Isl1 protein and the Cre recombinase in the Isl1Cre strain label the pharyngeal endoderm,
surface ectoderm, arch core mesoderm and PAA endothelium (Fig. 3E, E′, F, F′; and
Supplemental Fig. 1), but not neural crest-derived cells in the pharyngeal arches (Fig. 3 and
Sup. Fig. 1). Consistent with these observations, the deletion of Fn1 in the neural crest did
not result in PAA formation defects (Fig. 6J–O′). In these experiments, we used
TFAP2αIRESCre, in which Cre is active in both the neural crest and the pharyngeal surface
ectoderm. Taken together, these experiments indicate that these latter two pharyngeal
sources of Fn1 are not required for PAA formation.
3.2. Integrin α5 is a major Fn1 receptor in Isl1+ cells and their descendants
Isl1+ progenitors contribute to multiple tissues within pharyngeal arches. These tissues
comprise the pharyngeal endoderm, mesoderm (including PAA endothelium), and surface
ectoderm (compare GFP+ patterns in Fig. 7A and B; See Sup. Fig. 1 for the full anteriorposterior view of coronal section through the pharyngeal arches). Fn1 protein expression is
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enriched at the tissue borders in the pharyngeal arches (Fig. 7C). Intriguingly, Fn1 mRNA is
particularly highly expressed in the endoderm of the 4th pharyngeal arch (double-headed
arrow in Fig. 7D). In order to understand the mechanisms by which pharyngeal Fn1
regulates cardiovascular development, we performed conditional mutagenesis to identify
Fn1 receptors and to determine the cell types responding to Fn1 signals in the pharyngeal
arches. We focused our attention on integrin α5β1 since we and others have shown that
phenotypes of integrin α5-null mice closely resemble those of Fn1-null mutants (George et
al., 1993, 1997; Goh et al., 1997; Mittal et al., 2010, 2013; Pulina et al., 2011, 2014;
Takahashi et al., 2007; Yang et al., 1999; Yang et al., 1993).
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Immunofluorescence staining indicated that integrin α5 is expressed in all pharyngeal cell
types (Fig. 7E) and is particularly enriched in the PAA endothelium (e.g. open arrowheads in
Fig. 7E and F). To determine whether integrin α5β1 regulated cardiovascular morphogenesis
downstream of Fn1, we used the Isl1Cre knock-in mice to ablate integrin α5. This strategy
resulted in efficient downregulation of integrin α5 in the surface ectoderm, splanchnic and
pharyngeal mesoderm, myocardium, and in the endoderm in integrin α5flox/−; Isl1Cre
mutants at E8.5 (compare Fig. 8A, A′ and B, B′). At E10.5, we observed downregulation of
integrin α5 in the PAA endothelium, endoderm and surface ectoderm in the pharyngeal
arches of integrin α5flox/−; Isl1Cre mutants (Fig. 8C, D and C′, D′). Taken together, these
studies indicate that the use of the Isl1Cre knock-in mice resulted in the downregulation of
integrin α5 in the expected cell types.

Author Manuscript

The deletion of integrin α5 in tissues derived from Isl1+ cells was embryonic lethal in the
majority of the cases (Table 4), and resulted in phenotypes that closely corresponded with
those observed in Fn1flox/−; Isl1Cre mutants (Fig. 9), Table 5. Similar to Fn1flox/−; Isl1Cre
embryos, integrin α5flox/−; Isl1Cre mutants displayed defects in AAA morphogenesis
(compare Fig. 9A–B and Fig. 9E–F), membranous and muscular VSD (compare Fig. 9C–C′
and Fig. 9G–H), and defects in thymus development (Fig. 9D, I, L). We observed a slightly
higher proportion of mutants with abnormal alignment of the great vessels relative to the left
and right ventricles in integrin α5flox/−; Isl1Cre embryos (n = 4/10) than in Fn1flox/−; Isl1Cre
mutants (compare Fig. 9C, C′ with Fig. 9K, K′, showing double outlet right ventricle in the
mutant); see Tables 2 and 5. However, this difference in frequency did not reach statistical
significance (p = 0.14, 2-tailed Fisher exact test). Membranous VSD (n = 7/14), peri-aortic
cartilage (n = 3/12) and thymus defects (n = 10/15) were present in integrin α5flox/−;
TFAP2αIRESCre mutants (Fig. 9M–R). Peri-aortic cartilage results from the abnormal
differentiation of neural crest cells (Gao et al., 2010). Taken together, our data suggest that
signaling mediated by Fn1-integrin α5β1 interactions in neural crest cells is important for
ventricular septation and suppression of differentiation of neural crest cells into the cartilage.
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Analogous to Fn1flox/−; Isl1Cre mutants, we found that defective PAA formation at E10.5
was the basis for RERSA and IAA-B defects in integrin α5flox/−; Isl1Cre mutants (Fig. 10A–
H), Table 6. The left, right, or both PAAs were affected in individual integrin α5flox/−;
Isl1Cre embryos, Table 6. This is similar to the PAA phenotypes observed with Fn1flox/−;
Isl1Cre mutants (Fig. 6A–H′). The slight increase in the incidence of bilateral PAA defects in
integrin α5flox/−; Isl1Cre mutants relative to Fn1flox/−; Isl1Cre mutants (Table 6) was not
statistically significant (p = 0.32, 2-tailed Fisher exact test). As in Fn1flox/−; Isl1Cre mutants,
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endothelial proliferation was not affected in integrin α5flox/−; Isl1Cre embryos (Fig. 10I).
Finally, deletion of integrin α5 in the neural crest and surface ectoderm using the
TFAP2αIRESCre knock-in strain did not result in PAA formation defects (Fig. 10J–K′). This
indicates that signaling by integrin α5 in these tissues is dispensable for PAA formation.
Taken together, similarities in the phenotypes between integrin α5flox/−; Isl1Cre and
Fn1flox/−; Isl1Cre mutants suggest that Fn1 regulates cardiac morphogenesis and PAA
formation by signaling through integrin α5.
3.3. Integrin α5 does not regulate the expression of Tbx1

Author Manuscript

Cardiovascular phenotypes of Fn1flox/−; Isl1Cre and integrin α5flox/−; Isl1Cre mutants fall
within the range of phenotypes observed in DiGeorge syndrome. Therefore, we investigated
whether integrin α5 regulates the expression of the transcription factor Tbx1. The Tbx1 gene
is often deleted or mutated in DiGeorge patients (Moon, 2006, 2008). Heterozygous deletion
of Tbx1 in mice gives rise to defects in the formation of the 4th pair of PAAs and in AAA
morphogenesis (Liao et al., 2004; Lindsay and Baldini, 2001; Lindsay et al., 2001; Merscher
et al., 2001). However, Tbx1 expression was unaffected in n = 4/4 integrin α5flox/−; Isl1Cre
mutants, suggesting that Tbx1 expression is not regulated by integrin α5 signaling in tissues
derived from Isl1-expressing cells (Fig. 10L).
3.4. Fn1 and integrin α5 regulate OFT morphogenesis

Author Manuscript
Author Manuscript

Proper vascular development is dependent on hemodynamic forces, and hence on the
development and function of the heart (Culver and Dickinson, 2010; Lucitti et al., 2007; Luo
et al., 2001). Therefore, we examined cardiac development in Fn1flox/−; Isl1Cre and integrin
α5flox/−; Isl1Cre mutants. In our previous studies using global, Fn1-null and integrin α5-null
embryos, we discovered that Fn1 and integrin α5 were required for the elongation of the
cardiac OFT (Mittal et al., 2013). Since the global ablation of Fn1 or integrin α5 led to
multiple embryonic morphogenetic defects, it was not clear whether Fn1 and integrin α5
played direct roles in OFT development. The OFT is derived from Isl1+ second heart field
cells (Cai et al., 2003). To determine whether defects in PAA formation were correlated with
abnormal cardiac morphogenesis, we examined OFT development in E10.5 Fn1flox/−; Isl1Cre
mutants with defective and normal PAAs. Our data indicate that, on average, the relative
lengths of the proximal and distal portions of the OFT were shorter in Fn1flox/−; Isl1Cre and
integrin α5flox/−; Isl1Cre mutants compared with controls (Fig. 11). However, when mutants
were examined individually, defective PAAs were present in mutants with normal OFTs and
normal PAAs were present in mutants with defective OFT (Fig. 11G). Statistical analysis
showed that the presence of short OFT did not correlate with defective PAA formation in the
mutants (p = 0.16, Fisher exact test). Since myocardial development was unaffected in 91%
of our mutants, Tables 2 and 5, we conclude that the roles of Fn1 and integrin α5 in PAA
development are independent from their roles in OFT morphogenesis.
3.5. Integrin α5 regulates PAA formation indirectly
In order to identify the cell type(s) in which signaling by integrin α5 regulates PAA
formation, we performed a series of conditional mutagenesis studies to ablate integrin α5 in
distinct pharyngeal cell types. Since the expression of integrin α5 was downregulated in the
PAA endothelium of integrin α5flox/−; Isl1Cre mutants (Fig. 8C,C′,D, D′), we tested whether
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the expression of integrin α5 in the pharyngeal arch endothelium was required for the
formation of the 4th PAA. For these experiments, we used the knock-in Mesp1Cre strain to
ablate integrin α5, since Mesp1+ progenitors give rise to the entire pharyngeal mesoderm
including the PAA endothelium (Liang et al., 2014; Papangeli and Scambler, 2013b). Our
published studies indicated that the expression of integrin α5 in Mesp1-derived mesoderm,
including the PAA endothelium was not required for PAA formation (Liang et al., 2014).
This concurred with the observation that the deletion of integrin α5 in the endothelium using
the transgenic Tie2-Cre mice did not cause defects in PAA formation (van der Flier et al.,
2010). Taken together, these studies indicate that integrin α5 regulates PAA formation
indirectly by signaling from within the cell type(s) other than endothelial cells or the
mesoderm. The corollary of these studies is that signaling by Fn1 to the pharyngeal
mesoderm and endothelium is not required for PAA formation. Thus, signaling by Fn1 and
integrin α5 to other pharyngeal tissues regulates PAA formation indirectly.
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We next ablated integrin α5 in the neural crest using the P3-ProCre strain, or
simultaneously, in the neural crest and the surface ectoderm using the TFAP2αIRESCre strain.
PAA formation was unaffected in these mutants (Fig. 10 and data not shown). Taken
together, these data indicate that integrin α5-dependent signaling in a tissue other than the
mesoderm, neural crest, and surface ectoderm is important for PAA formation.

Author Manuscript

Even though, integrin α5 is uniformly expressed by the pharyngeal endoderm (Figs. 7E,
inset and 8C, C′), the expression of Fn1 mRNA is enriched specifically in the endoderm of
the 4th pharyngeal arch (Fig. 7D). This expression pattern is consistent with our findings
that formation of the 4th PAA is selectively affected in Fn1flox/−; Isl1Cre and integrin
α5flox/−; Isl1Cre mutants, and suggests that integrin α5-dependent signaling by Fn1 to the
endoderm of the 4th pharyngeal arch may be particularly important. Although the expression
of integrin α5 is lower in the endoderm of the 4th arch compared with other pharyngeal arch
cell types (Figs. 7E and 8C′) at E10.5, its levels may be sufficient for signaling, especially,
given the presence of enriched levels of Fn1 mRNA synthesized by these cells (doubleheaded arrow in Fig. 7D). Thus, we propose a model, wherein an (as yet unknown) integrin
α5-dependent signal from the pharyngeal endoderm regulates PAA formation (Fig. 12).

4. Conclusions
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Fn1 is highly conserved in all vertebrates (Hynes, 2012; Hynes and Zhao, 2000; Whittaker et
al., 2006); it is prominently expressed around embryonic blood vessels, and its vascular
expression and alternative splicing are tightly regulated upon injury in adult, reviewed by
(Astrof and Hynes, 2009). However, direct roles of Fn1 in the development of the heart and
blood vessels were obscured by severe morphogenetic defects that occurred at earlier stages
of embryogenesis in global, Fn1-null embryos (George et al., 1997; George et al., 1993;
Pulina et al., 2014; Pulina et al., 2011). Our data show that Fn1 regulates the development
cardiac and vascular structures, and highlight an intriguing discovery that localized, cellspecific expression of the secreted ECM glycoprotein Fn1 is essential for embryogenesis and
cardiovascular development. We found that Fn1 synthesized by Isl1-expressing cells and
their descendants is required for the morphogenesis of the cardiac OFT, for the formation of
the cardiac interventricular septum, thymus development, and formation of the 4th pair of
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PAAs. Integrin α5flox/−; Isl1Cre mutants displayed similar defects as Fn1flox/−; Isl1Cre
embryos, suggesting that integrin α5 acts as a main Fn1 receptor in the pharyngeal region.
Taken together, our experiments provide the first evidence for the direct involvement of Fn1
and integrin α5 in the regulation of cardiovascular morphogenesis.

5. Discussion

Author Manuscript

Pharyngeal arches are composed of cells derived from all three embryonic germ layers and
consist of the endoderm, mesoderm, surface ectoderm, and neural crest-derived (Hutson and
Kirby, 2007). The PAA endothelium is derived from mesodermal progenitors that express
the Mesp1 transcription factor early in gastrulation (Liang et al., 2014; Papangeli and
Scambler, 2013b). While the mechanisms of PAA formation are not well understood, PAA
development is known to rely on signaling interactions among all cell types that compose
the pharyngeal arch (Astrof, 2013). PAA formation can be regulated directly, by signaling
within the mesoderm, and indirectly, by signaling from the pharyngeal epithelia, the
endoderm, and the surface ectoderm. For example, PAA formation requires the surface
ectoderm to express the Tbx1 and Gbx2 transcription factors and the Fgf8 growth factor
(Calmont et al., 2009; Macatee et al., 2003). In the mesoderm, PAA formation requires the
expression of Tbx1, PlexinD1, as well as activation of Notch and retinoic acid pathways
(Gitler et al., 2004; High et al., 2009; Li et al., 2012; Zhang et al., 2009; Zhang et al., 2006).
Taken together, these and other studies illustrate the complex intercellular signaling
interactions that regulate PAA formation.
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In Fn1flox/−; Isl1Cre mutants, Fn1 is ablated in the pharyngeal embryonic tissues that include
splanchnic and pharyngeal mesoderm, pharyngeal endoderm, surface ectoderm, and select
populations of neural crest cells. Which of these source(s) of Fn1 is(are) required for
cardiovascular development, and do different sources of Fn1 regulate distinct morphogenetic
processes? To address these questions we performed conditional mutagenesis studies by
ablating Fn1 expression in distinct cell types within the expression domain that encompasses
Isl1+ cells and their descendants. These studies showed that Fn1 expression in neural crestderived cells, surface ectoderm and their derivatives are important for thymus development,
for blocking the differentiation of cardiac neural crest cells into the cartilage, and for the
development of the membranous ventricular septum but are not required for the formation of
the 4th PAA. Conditional mutagenesis studies to ablate Fn1 in other pharyngeal tissues are
currently ongoing.
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Identification of cell type(s) that regulate cardiovascular morphogenesis in response to Fn1
is essential for uncovering the downstream pathways engaged by Fn1 in vivo. To accomplish
this, we first asked whether the expression of integrin α5β1 in Isl1+ tissues and their
descendants was necessary for cardiovascular development and compared the phenotypes of
integrin α5flox/−; Isl1Cre embryos with those of Fn1flox/−; Isl1Cre mutants. We found that the
phenotypes of integrin α5flox/−; Isl1Cre embryos are indistinguishable from those of
Fn1flox/−; Isl1Cre mutants, suggesting that Fn1 expressed by the pharyngeal tissues regulates
cardiovascular morphogenesis by signaling through integrin α5β1.
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Global mutation in integrin α5 led to severe cardiovascular defects, however, whether
integrin α5 played a direct role in cardiovascular development was difficult to discern due to
the complicating morphogenetic defects in these embryos (Pulina et al., 2011, 2014; Yang et
al., 1993). Conditional knockouts of integrin α5 in a number of different cell types, such as
endothelial cells, using the Tie2-Cre transgenic line (van der Flier et al., 2010), in lymphatic
endothelial cells and mesodermal precursors of mural cells, using the PDGFRβ-Cre
transgenic line (Turner et al., 2014), in the pharyngeal mesoderm and endothelium, using the
Mesp1Cre knock-in strain (Liang et al., 2014) and in smooth muscle cells, using the SM22αCre transgenic line (Turner et al., 2015), showed that the expression of integrin α5 in these
cell types did not affect blood vessel formation. This suggested that concomitant signaling
by integrin α5 from multiple cell types may be important for cardiovascular development
(van der Flier et al., 2010) and/or that cardiovascular defects in global integrin α5-null
embryos arose as a consequence of other embryonic abnormalities in these mutants (Goh et
al., 1997; Mittal et al., 2010, 2013; Pulina et al., 2011, 2014; Yang et al., 1993). Consistent
with these ideas, the ablation of integrin α5 in multiple cell types using the Isl1Cre knock-in
strain demonstrated that integrin α5 expression in multiple pharyngeal tissues plays requisite
roles in the regulation of cardiovascular morphogenesis. Particularly interesting is the role of
integrin α5 and Fn1 in the formation of the 4th PAA. While we do not yet understand the
mechanisms, it is important to note that the roles of integrin α5 and Fn1 in cardiac
development are separate from their functions in the formation of the 4th PAAs, since
cardiac and PAA defects occurred independently of one another.
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To determine the cell types, in which signaling by α5β1 regulates cardiovascular
development, we performed conditional mutagenesis studies to ablate integrin α5 in distinct
tissues within the Is1-expression domain and its derivatives. We found that the expression of
α5β1 in the neural crest or in the Mesp1-derived mesoderm (Liang et al., 2014) was required
for the formation of the membranous ventricular septum. These studies suggested that the
expression of integrin α5β1 in both the neural crest-derived cells and the mesoderm jointly
regulates the development of the membranous ventricular septum. Interestingly, and
consistent with the studies of (Haack and Hynes, 2001; Turlo et al., 2012), our work
indicates that neither Fn1 nor integrin α5 are required for the migration of NC-derived cells.
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Mesp1-derived cells include splanchnic mesoderm and all of the known pharyngeal
mesodermal cells and their derivatives, such as the OFT and PAA endothelial cells.
Interestingly, the expression of integrin α5 in the Mesp1-derived mesoderm was not required
for PAA formation. Similarly, concomitant ablation of integrin α5 in the neural crest-derived
cells and the surface ectoderm did not affect the formation of the PAAs. These studies
suggest the pharyngeal endoderm as an important integrin α5 expression domain regulating
PAA formation.
Fn1 and integrin α5 are prominently expressed in the pharyngeal endoderm at E8.5 (Figs.
1B′, 7D, and 8A–A′). At the later embryonic stages, the expression of integrin α5
diminishes but is clearly detectable in the endoderm of the pharyngeal arches at E10.5 (Figs.
7E and 8C, C′). Remarkably, the expression of Fn1 mRNA becomes highly enriched in the
endoderm of the 4th PAAs at E10.5 (Fig. 7D), potentially explaining why the development
of the 4th PAAs is particularly defective in Fn1flox/−; Isl1Cre and integrin α5flox/−; Isl1Cre
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mutants. Taken together with our conditional mutagenesis studies, these data suggest that
Fn1 synthesized by the endoderm mediates the formation of the 4th PAAs indirectly by
signaling to the endoderm of the 4th pharyngeal arch through integrin α5β1. This hypothesis
needs to be carefully and directly evaluated in the future, since many factors such as
potential differences in strains’ genetic backgrounds (all of our mice are on a mixed 129C57BL/6J background), differences in the efficiency and timing of the genetic deletion, as
well as other factors may influence PAA formation in the mutants utilized in our work. As
an alternative to our model, concomitant integrin α5-dependent signaling in multiple
pharyngeal tissues may be required to mediate PAA formation.
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How pharyngeal endoderm may regulate PAA development is currently unknown. However,
it is well established that both vasculogenesis and angiogenesis can be regulated by signals
extrinsic to endothelial cells (Adams and Alitalo, 2007; Bressan et al., 2009; Garriock et al.,
2010; Meadows et al., 2012). By circumventing early embryonic lethality, our conditional
mutagenesis strategy will facilitate identification of cellular and molecular mechanisms by
which Fn1 and integrin α5β1 regulate embryogenesis and cardiovascular development.
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Conditional ablation of Fn1 in pharyngeal tissues using the Isl1Cre knock-in strain. All
embryos are at E9.5. Brackets in all panels mark the pharyngeal region where arches 3, 4,
and 6 will develop. Long arrows in (A–E) point to the neural crest. (A–A′) Fate map of Isl1+
cells and their descendants; Dashed line in A marks approximate planes of sections shown in
(A′–E′), open arrowhead points to endocardium in A′–C′. (B-B′) Fn1 mRNA expression is
enriched in the surface ectoderm (arrowhead in B′), pharyngeal pocket endoderm (small
black arrow), mesoderm, and endocardium (arrowhead). (C-C′). Fn1 mRNA is ablated in
the pharyngeal tissues following Cre-mediated recombination in Fn1flox/−; Isl1Cre mutants.
Myocardium (white arrow) does not express Fn1. Short arrows in (B–C) point to somites,
where Isl1Cre is not expressed and Fn1 expression is unaltered. (D) Expression of Fn1
protein is enriched in the posterior pharyngeal arches (bracket). E. Fn1 protein is depleted
from the pharyngeal region in Fn1flox/−; Isl1Cre mutants. (D′–E′) Transverse sections
through (D–E). Fn1 is depleted in pharyngeal arches and the heart (h) in Fn1flox−; Isl1Cre
mutants (E′). Fn1 remains expressed by the neural crest-derived cells (arrowhead in E′) and
by more dorsal regions, including the dorsal aorta (short arrows in D′–E′); g - gut, LV, RV left and right ventricles, NT - neural tube. Scale bars in (A–E) are 500 µm; in (A′–E′) 100
µm.
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Cardiovascular and thymus defects in Fn1flox/−; Isl1Cre mutants at E16.5. (A–E) Fn1flox/+;
Isl1Cre controls. (F–J) Fn1flox/−; Isl1Cre mutants. All sections are cut in a coronal orientation
and stained with H&E. A. Ventral view. Ao - ascending aorta, PT - pulmonary trunk; arrow
points to the arch of aorta. (B) Dorsal view, arrow points to the right subclavian artery. (C)
Ventral view, arrow points to a high branch-point of the left carotid artery. (D–E) Complete
septum separates the right and left ventricles (RV and LV). Aorta (arrow) originates from the
LV. (F) Arrow points to the absent aortic arch. (G) Arrow and the dashed line highlight the
right subclavian artery aberrantly originating from the descending aorta, dAo. (H) Arrow
points to the low branch point of the right carotid artery. (I) Membranous septum defect,
arrow. (J) Muscular septum defect, arrow. H&E stained sections in (D) and (I) and in(E) and
(J) show views at equivalent section levels. (K–L′). Fn1flox/+; Isl1Cre controls. (M–P)
Fn1flox/−; Isl1Cre mutants. (K), (K′), (M–N′) are H&E stained sections. (K) Aorta and
pulmonary trunk are two separate vessels in controls. K′. Histology of the suboartic region
outlined by the dashed box in (K). (L) Thymus. (L′) The same as L, but with the two lobes
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outlined by the dashed line. (M) * marks the region where Ao and PT are fused in the
Fn1flox/−; Isl1Cre mutant. (N–N′) Histology of the subaortic region. The dashed region in
(N) is magnified in N′ and shows cartilage-like nodule, white arrow. (O–P) Dashed regions
outline the asymmetric thymus lobes in O and a single thymus lobe in (P). Scale bars are
500 µm in all panels, except they are 100 µm in (K), (M), (N) and 10 µm in (K′), (N′).

Author Manuscript
Author Manuscript
Author Manuscript
Dev Biol. Author manuscript; available in PMC 2017 February 16.

Chen et al.

Page 22

Author Manuscript
Author Manuscript

Fig. 3.

Author Manuscript

Neural crest-derived cells in the cardiac outflow tract express Isl1. (A–C), (A′–C′)
Transverse sections through TFAP2αIRESCre; ROSAmTmG embryos isolated at E9.5. Boxed
regions in (A–D) are expanded in (A′–D′). (A–C) Fate map of TFAP2αIRESCre - expressing
cells and their descendants. GFP (green) marks both the surface ectoderm (short arrows in
A–B) and neural crest-derived cells, marked by the open arrowheads and open arrows.
Arrowheads point to Isl1+ neural crest-derived cells and arrows point to Isl1-negative neural
crest cells. Isl1 staining is in red. (A–A′). Section is at the level of the outflow tract (OFT,
long arrow). AoS-aortic sac. (B–B′) Section is at the level of the 3rd pharyngeal arch. (C–C
′) Section is at the level of the 4th pharyngeal arch. Open arrows point to IslGFP+
pharyngeal neural crest cells, arrows in (B′–C′) point to Isl+GFP− pharyngeal mesoderm,
and a small arrowhead in (C′) points to Isl+GFP splanchnic mesoderm. (D–D′) E9.5
embryos. Transverse section at the OFT level shows lineage map of Mesp1-derived cells
(GFP+, green) and TFAP2α expression (red, small arrows in D). OFT myocardium
originates from Mesp1-derived cells (long arrow in D′). TFAP2α+GFP− cells (open
arrowheads) in the OFT are not derived from the mesoderm. (E–E′), (F–F′) E10.5 embryos.
Boxed areas in (E–F) are expanded in (E′–F′). (E) The majority of neural crest cells in the
pharyngeal arches are Isl1GFP+. Isl1+GFP− cells form the arch core mesoderm (boxed in E,
expanded in E′) and PAA endothelium (arrows in F′). Native GFP and Tomato fluorescence
in all sections were extinguished by mounting sections in 50/50 MeOH/Glycerol, see
Methods. Scale bars are 100 µm in (A–D), (E–F), 30 µm in (A′–D′), 20 µm in (E′–F′).
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Fig. 4.

Cardiovascular and thymus defects in Fn1flox/−; TFAP2αIRESCre mutants at late gestation.
(A–C) Fn1flox/+; TFAP2αIRESCre controls; (D–F) Fn1flox/−; TFAP2αIRESCre mutants; (G–I)
Fn1flox/+; P3Pro-Cre+ controls; and (J–L) Fn1flox/−;P3Pro-Cre+ mutants. All sections were
cut in coronal orientation. (A, D, G, J) - H&E staining. Slim arrows in (D) and (J) point to
the membranous ventricular septal defect (VSD). Ao - ascending aorta. PT - pulmonary
trunk, RV-right ventricle, LV - left ventricle. (B, E, H, K) - Alcian blue and nuclear fast red
staining. Cartilage in the mutants is stained in blue (dashed box, expanded in insets of E and
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K). (C, F, I, L) - whole isolated thymus lobes. Mutants display hypoplastic and asymmetric
thymus lobes (F, L). Scale bars: 100 µm in (A), (D), (G), and (J); 200 µm in (B), (E), (H),
and (K); 500 µm in (C), (F), (I), and (L).
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Fig. 5.

Isl1 lineage map of the thymus and thymus vasculature in control and Fn1flox/−; Isl1Cre
mutants. Sections through the thymus isolated from E16.5 embryos. (A-A′) Section from
Isl1Cre;ROSAmTmG embryo. The bulk of the thymus and thymus endothelial cells (Pecam1,
blue, arrowhead in A′) are derived from Is1+ cells. Pericytes (NG2, red, arrows) in the
thymus are not of the Isl1+ lineage. Thymi from control (B–C) and Fn1flox/−; Isl1Cre mutant
embryos (D–E) were stained to detect endothelial cells (Pecam1, green), pericytes
(PDGFRβ, red, arrows) and nuclei (DAPI, blue). 40 × (B–B′; D–D′) and 63 × (C–C′, E–E′)
images are shown. All scale bars are 100 µm, except in C–C′ and E–E′, where they are 10
µm.
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Expression of Fn1 in the Isl1-derived tissues regulates formation of the 4th PAAs. All
images in (A–M) are from E10.5 embryos. PAAs are numbered. (A–D) Intracardiac India
ink injections label the PAAs. All PAAs are visible in controls (A–B). The right 4th PAA
(arrow) is non-patent in the Fn1flox/−; Isl1Cre mutant (C–D). E-H. Whole mount Pecam1
staining (green) and 3D–confocal image reconstruction show well-formed PAAs in controls
(E–F), and bi-laterally thin 4th PAAs in the Fn1flox/−; Isl1Cre mutant, arrows (G–H). Dashed
lines in (E–H) mark optical planes of section shown in (E′–H′). Pecam1 (blood vessels,
green) and DRAQ5 (nuclei, blue). Arrows point to pharyngeal arches with thin/disorganized
PAAs. Scale bars are 100 µm; R - right, L - left. I. BrdU incorporation into endothelial cells
in controls (white bars) and mutant (gray bars) embryos; Each dot represents measurements
in one pharyngeal arch; p was determined using 2-tailed, unpaired Student′s t test. (J–O′)
Expression of Fn1 in the neural crest and the surface ectoderm is not required for PAA
formation. (J–M) India ink injections at E10.5. All PAAs are visible in control Fn1flox/+;
TFAP2αIRESCre and mutant Fn1flox/−; TFAP2αIRESCre embryos at E10.5. (N–O′) Coronal
sections through E11.5 embryos show that all PAAs (numbered 3–6) are formed normally in
control Fn1flox/+; TFAP2αIRESCre and mutant Fn1flox/−; TFAP2αIRESCre embryos. Neural
crest is stained using anti-GFP antibodies (blue), due to the presence of the ROSAmTmG
allele and endothelium is labeled with anti-Pecam1 antibodies (white). Red dashed lines
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outline the endoderm (en). Native GFP and tdTomato fluorescence was extinguished by
boiling sections in 10 mM Citric Acid pH 6.0 as described in Methods.
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Lineages labeled in the Isl1Cre and TFAP2αIRESCre strains and expression patterns of Fn1
and integrin α5 in the 4th pharyngeal arch at E10.5. (A–A″) Isl1Cre; ROSAmTmG. (B–B″)
TFAP2αIRESCre; ROSAmTmG. Native GFP and tdTomato fluorescence was extinguished by
boiling in 10 mM Citric Acid pH 6.0 as described in Methods. C. Fn1 protein (white). (D)
Fn1 mRNA (brown). (E) Integrin α5 protein (white); Arrows in the inset point to integrin α5
expression in the endoderm. (F) Same section as in (E) co-stained with antibodies to
VEGFR2 (white). Endo–endoderm; arrowheads point to ectoderm; Pharyngeal arches are
numbered; Scale bars in (A–B) 30 µm; scale bars in (C–F) 50 µm.
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Ablation of integrin α5 using the Isl1Cre strain. (A–B) Transverse sections through E8.5
embryos. Integrin α5 – red, nuclei – blue. (A–A′) Control. (B–B′) Mutant. Boxed regions in
A and B are expanded in A′ and B′. Arrows – endoderm; open arrows – splanchnic
mesoderm; closed arrowheads – myocardium; open arrowheads – ectoderm. (C–D) Coronal
sections through the 4th pharyngeal arch in E10.5 control (C, C′) and mutant (D, D′)
embryos. Integrin α5 – red, VEGFR2 (endothelium) – green. Open arrows point to PAA
endothelium; Long arrows in (C′), (D′) point to the endoderm;. All scale bars are 50 µm.
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Fig. 9.

Cardiovascular and thymus defects inintegrin α5flox/−; Isl1Creand in integrin α5flox/−;
TFAP2αIRESCre mutants at E16.5 and E17.5. (A–D) Controls; E-L Mutants. (A, E, D, I, L) ventral views; (B, F) - dorsal views. Ao - ascending aorta; PT - pulmonary trunk; Long
arrow in A points to the aortic arch; dAo-descending aorta is marked in (B). (C) PT
originates from the right ventricle (RV) in controls; Ao originates from the left ventricle
(LV) in controls; (D) two symmetrical thymus lobes of a control embryo are outlined. (E)
Arrow points to the missing aortic arch; (F) Arrowhead points to the subclavian artery
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originating from the dAo. (G) Arrow points to the membranous ventricular septal defect
(VSD); This mutant also has an overriding aorta, receiving the blood from the RV and LV.
(H) Arrow points to the muscular septal defect in the mutant. (I, L). Three thymus lobes are
outlined in the mutants. (J–J′) Subaortic cartilage nodule in the mutant (boxed). The box in J
is expanded in (J′), arrow in (J′) points to the cartilage. (K–K′) Double outlet right
ventricle: both the PT (K) and Ao (K′) originate from the right ventricle in this mutant. (M–
O). Integrin α5flox/+; TFAP2αIRESCre controls. (P–R) Integrin α5flox/−; TFAP2αIRESCre
mutants. All sections were cut in coronal orientation and stained with Alcian blue and
nuclear fast red. Boxed regions in M and (P) are expanded in (M ‘) and (P′). Cartilage in the
mutants is stained blue (boxed region in P and arrow in P′). Arrow in (Q) points to the
membranous VSD. Asymmetric and hypoplastic thymus lobes in integrin α5flox/−;
TFAP2αIRESCre mutant are outlined in (R). All scale bars are 500 µm, except they are 100
µm in (J) and 50 µm in (J′).
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PAA defects in α5flox/−; Isl1Cre mutants at E10.5. (A–D) 3D reconstructions of whole mount
confocal data from Pecam1-stained embryos. L-left; R-right. Each PAA is labeled. The
boxed regions in (B) and (D) are expanded in (B′) and (D′). Arrows point to the 4th PAAs
in the control and mutant. Vertical doted lines are the planes of sections shown in (E–F) and
(G–H). (E, G) - right sides; (F, H) - left sides. Arrow in (H) points to the 4th arch with the
defective PAA. All scale bars are 100 µm. (I) BrdU incorporation into endothelial cells in the
4th pharyngeal arches. (J-J′), (K-K′). Coronal sections through E11.5 pharyngeal regions in
integrin α5flox/+; TFAP2αIRESCre control (J-J′) and integrin α5flox/−; TFAP2αIRESCre
mutant (K-K′) embryos. PAAs (numbered 3–6) form normally in control
Fn1flox/+;TFAP2αIRESCre and mutant Fn1flox/−; TFAP2αIRESCre embryos. Neural crest is
stained using anti-GFP antibodies (blue), due to the presence of the ROSAmTmG allele and
the endothelium is labeled with anti-Pecam1 antibodies (white). Red dashed lines outline the
endoderm (en). Native GFP and tdTomato fluorescence was extinguished by boiling in 10
mM Citric Acid, pH 6.0 as described in Methods. (L) Expression levels of integrin α5 and
Tbx1 mRNA in the mutants (gray bars) were normalized to those of control embryos (white
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bar). For (I) and (L): each data point represents one arch; p was determined using 2-tailed,
unpaired Student’s t test.
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Defects in OFT elongation in Fn1flox/−; Isl1Cre and integrin α5flox/−; Isl1Cre mutants are not
correlated with the defects in PAA formation at E10.5. In A-F. Dotted brackets mark the
lengths of the distal and proximal OFT. Red brackets mark OFT lengths that differ from
controls, white brackets mark OFT lengths that are similar to controls. (A′-F′) Doubleheaded arrows mark the heights of the left ventricle. (A-C, D-F) Right side views. (A′-C′, D
′-F′) Left side views. All scale bars are 200 µm. G. Normalized lengths of the proximal and
distal OFT. Red symbols mark embryos with defective PAAs. Control embryos, (unfilled
circles) were collected from Fn1 and integrin α5 crosses and their genotypes are marked in
H. H. Normalized OFT lengths in control embryos from Fn1 and integrin α5 crosses. (G–H)
Each symbol represents one embryo. p-Value was determined using 2-tailed, unpaired
Student’s t test.
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Fig. 12.

Summary of PAA formation phenotypes resulting from the ablation of integrin α5 using the
Isl1Cre, Mesp1Cre, and TFAP2αIRESCre strains. Green color marks the tissues in which
integrin α5 was ablated in each strain. We hypothesize that an integrin α5-dependent signal
in the pharyngeal endoderm regulates PAA formation.

Author Manuscript
Dev Biol. Author manuscript; available in PMC 2017 February 16.

Author Manuscript

Author Manuscript

Author Manuscript
342
179
188

E10.5

E13.5–18.5

3 weeks

66(35%)

46(26%)

88(26%)

88(23%)

Fn1flox/+

49(34%)

58(32%)

87(25%)

88(23%)

Fn1flox/+; Isl1Cre

50(29%)

51(28%)

83(24%)

101(26%)

Fn1flox/−

9(5%)

24(13%)

84(25%)

109(28%)

Fn1flox/−; Isl1Cre

Each column reports the number of embryos or mice (at 3 weeks) observed of each genotype

386

Total # of embryos

E8.5–9.5

Age

Conditional knockout of Fn1 using the Isl1Cre strain is embryonic and neonatal lethal.

Author Manuscript

Table 1
Chen et al.
Page 36

Dev Biol. Author manuscript; available in PMC 2017 February 16.

Author Manuscript

Author Manuscript

E15.5

E15.5

E16.5

E16.5

E16.5

E16.5

E16.5

E17.5

E17.5

E17.5

E18.5

E18.5

1

2

3

4

5

6

7

8

9

10

11

12
5/7 (71%)

N/E

N/A

N/A

ABCCA

ABCCA

ABCCA

ABCCA

N/E

N/E

N/E

ABCCA

N/E

3rd PAArelated

5/12 (42%)

IAA-B

N/A

RERSA

N/A

N/A

N/A

N/A

IAA-B

RERSA

N/A

RERSA

N/A

4th PAArelated

1/12 (8%)

DORV

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Alignment of the great
vessels

9/11 (82%)

N/E

Peri-aortic nodule

Peri-aortic nodule

N/A

Peri-aortic nodule

Peri-aortic nodule

Peri-aortic nodule

Membranous VSD, PTA (Van Praagh A4)

N/A

Membranous VSD

peri-aortic nodule

Membranous VSD, peri-aortic
nodule

Membranous VSD and subaortic cartilage

4/11 (36%)

N/E

Muscular VSD

Reduced compact zone (RV)/trabeculation (RV+LV)

N/A

Muscular VSD

N/A

N/A

N/A

Muscular VSD

N/A

N/A

N/A

Muscular VSD, myocardial
defects

7/11 (64%)

N/E

R hypoplastic (severe)

L fragmented

R hypoplastic (severe)

Single fused lobe

L hypoplastic
(moderate)

Slightly asymmetric

R/L ectopic; L
fragmented

Slightly asymmetric

Slightly asymmetric

R hypoplastic
(moderate)

Slightly asymmetric

Thymus

Abbreviations: AAA – aortic arch artery; ABCCA – aberrant branch point of common carotid artery; DA – ductus arteriosus; DORV – double outlet right ventricle; IAA-B – interrupted aortic arch type B;
L – left, R – right; N/A – not affected; N/E – not examined; OA – overriding aorta; PTA – persistent truncus arteriosus; RERSA – retroesophageal right subclavian artery; VSD – ventricular septal defect.

Summary

Stage

Embryo #

Author Manuscript

Cardiovascular and thymus defects in individual Fn1flox/−; Isl1Cre mutants.

Author Manuscript

Table 2
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Table 3

Author Manuscript

PAA formation in Fn1flox/−; Isl1Cre mutants.

Author Manuscript

Embryo
number

Number of
somites

Method of analysis

Right 4th PAA

Left 4th PAA

1

36–40

PECAM1/confocal

Thin

Thin

2

36–40

PECAM1/confocal

Thin

4th PA absent

3

36–40

PECAM1/confocal

Grossly normal

Thin

4

36

PECAM1/confocal

Grossly normal

Grossly normal

5

36

PECAM1/confocal

Grossly normal

Grossly normal

6

37

PECAM1/confocal

Grossly normal

Grossly normal

7

36–40

PECAM1/confocal

Grossly normal

Grossly normal

8

36–40

PECAM1/confocal

Grossly normal

Grossly normal

9

36–40

PECAM1/confocal

Grossly normal

Grossly normal

10

36–40

PECAM1/confocal

Grossly normal

Grossly normal

11

3 6 –40

PECAM1/confocal

Grossly normal

Grossly normal

12

36–40

PECAM1/confocal

Grossly normal

Grossly normal

13

36

Intracardiac ink injection

Thin

Grossly normal

14

37

Intracardiac ink injection

Thin

Grossly normal

15

36–40

Intracardiac ink injection

Thin

Grossly normal

16

36–40

Intracardiac ink injection

Thin

Grossly normal

17

3 6 –40

Intracardiac ink injection

Thin

Grossly normal

Penetrance: 8/18=44%(embryos); 9/35=26% (pharyngeal arches)

Author Manuscript
Author Manuscript
Dev Biol. Author manuscript; available in PMC 2017 February 16.

Author Manuscript

Author Manuscript

Author Manuscript
117
172

E13.5–18.5

3 weeks

61(35%)

28(24%)

58(34%)

9(20%)

Integrin α5f1ox/+

49(28%)

38(32%)

39(23%)

12(27%)

Integrin α5flox/+;
Isl1Cre

61(35%)

30(26%)

41(24%)

12(27%)

integrin α5flox/−

Each column reports the number of embryos or mice (at 3 weeks) observed of each genotype

44
169

E10.5

Total # of embryos

E8.5–9.5

Age

1(1%)

21(18%)

31(18%)

11(25%)

Integrin α5flox/−;
Isl1Cre

Conditional knockout of integrin α5 using the Isl1Cre strain is embryonic and neonatal lethal.

Author Manuscript

Table 4
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Author Manuscript

E17.5

e16.5

e16.5

e16.5

e18.5

6

7

8

9

10
2/10 (20%)

N/A

N/A

ABCCA

N/A

N/A

N/A

N/A

N/A

ABCCA

N/A

3rd PAArelated

5/10 (50%)

N/A

N/A

IAA-B

IAA-B

RERSA

N/A

N/A

RERSA

IAA-B

N/A

4th PAArelated

4/10 (40%)

N/A

N/A

N/A

OA

N/A

DORV

N/A

N/A

DORV

DORV, PT atresia, DA
absent

Alignment of the
great vessels

7/8 (88%)

Membranous VSD, peri-aortic
nodule

Peri-aortic nodule

N/A

Membranous VSD

N/E

N/E

Membranous VSD, peri-aortic
nodule

Membranous VSD

Membranous VSD

Membranous VSD

Membranous VSD and subaortic cartilage

3/8 (38%)

N/A

N/A

Muscular VSD

Muscular VSD

N/E

N/E

Muscular VSD, RV+LV reduced trabeculation

N/A

N/A

N/A

6/10 (60%)

L hypoplastic (severe), additional ectopic L lobe

R hypoplastic (severe)

R hypoplastic (severe); additional ectopic R lobe

Slightly asymmetric

R hypoplastic (severe)

Slightly asymmetric

L hypoplastic (moderate)

R hypoplastic (moderate)

Slightly asymmetric

Slightly asymmetric

Thymus

Abbreviations: AAA – aortic arch artery; ABCCA – aberrant branch point of common carotid artery; DA – ductus arteriosus; DORV – double outlet right ventricle; IAA-B – interrupted aortic arch type B;
L – left, R – right; N/A – not affected; N/E – not examined; OA – overriding aorta; PT – pulmonary trunk; RERSA – retroesophageal right subclavian artery; VSD – ventricular septal defect.

Summary

E17.5

E17.5

3

5

E17.5

2

E17.5

E17.5

1

4

Stage

Embryo #

Muscular VSD, myocardial
defects

Author Manuscript

Cardiovascular and thymus defects individual integrin α5 flox/−; Isl1Cre mutants.

Author Manuscript

Table 5
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Table 6

Author Manuscript

PAA formation in individual integrin α5 flox/−; Isl1Cre mutants.

Author Manuscript

Embryo number

Number of somites

Method of analysis

Right 4th PAA

Left 4th PAA

1

37

PECAM1/confocal

Thin

Thin

2

36

PECAM1/confocal

Thin

Grossly normal

3

36

PECAM1/confocal

Thin

Thin (mild)

4

36–40

PECAM1/confocal

Grossly normal

All plexus (no main artery)

5

36–40

PECAM1/confocal

Grossly normal

Thin

6

36–40

PECAM1/confocal

Thin

Grossly normal

7

36–40

PECAM1/confocal

Grossly normal

Grossly normal

8

36–40

PECAM1/confocal

Grossly normal

Grossly normal

9

36–40

PECAM1/confocal

Grossly normal

Grossly normal

10

36–40

PECAM1/confocal

Grossly normal

Grossly normal

11

36 –40

PECAM1/confocal

Grossly normal

Grossly normal

12

36–40

Intracardiac ink injection

Thin

Grossly normal

13

36–40

Intracardiac ink injection

Thin

Not patent in the middle

14

36–40

Intracardiac ink injection

Not patent

Grossly normal

15

36–40

Intracardiac ink injection

Not patent

Thin

16

36–40

Intracardiac ink injection

Not patent

Thin

17

36–40

Intracardiac ink injection

Grossly normal

Grossly normal

18

36–40

Intracardiac ink injection

Grossly normal

Grossly normal

Penetrance: 11/18 = 61% (embryos); 16/36 = 44% (pharyngeal arches)

Author Manuscript
Author Manuscript
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